Clinical Trial Update: An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers [Phase 4]

View source ↗

Summary

Open-label, Phase 4 study evaluating pharmacokinetics in subjects with mild and moderate hepatic impairment and healthy volunteers; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: ApoPharma | Conditions: Hepatic Impairment | Phase 4 | Status: COMPLETED | Results posted: 2014-09-10